(1-Sar, 8-Ile) angiotensin II in the treatment of inhalation injury: a pilot study.
The patients were three men and two women with moderate to severe inhalation injury. Each patient received immediate fluid therapy and all required intubation for respiratory management. At some time between 24 and 72 hours after the injury, the synthetic angiotensin analogue (1-Sar, 8-Ile) angiotensin II was infused at a rate of 100 ng/kg/min for 10 minutes, 200 ng/kg/min for another 10 minutes, and 300 ng/kg/min for 30 minutes. The mean (+/- SD) PaO2 increased from 80.8 +/- 26.9 mmHg before to 89.8 +/- 27.3 mmHg after the infusion (P < 0.05) and the PaCO2 decreased from 42.4 +/- 8.3 to 39.6 +/- 7.9 mmHg (P < 0.05). A transient pressor response was noted in all patients. The results suggest that this angiotensin II analogue may be of benefit in the treatment of inhalation injury and other types of acute lung injury.
Yukioka
T
T
Department of Traumatology and Critical Care Medicine, Kyorin University School of Medicine, Tokyo, Japan.
Shimazaki
S
S
Matuda
H
H
D015059:1-Sarcosine-8-Isoleucine Angiotensin II / Q000627:therapeutic use*; D000328:Adult; D002059:Burns, Inhalation / Q000188:drug therapy*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010865:Pilot Projects; D011659:Pulmonary Gas Exchange
D015059:1-Sarcosine-8-Isoleucine Angiotensin II